Richard Woolf

1.5k total citations
29 papers, 744 citations indexed

About

Richard Woolf is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, Richard Woolf has authored 29 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 15 papers in Dermatology and 6 papers in Rheumatology. Recurrent topics in Richard Woolf's work include Dermatology and Skin Diseases (13 papers), Psoriasis: Treatment and Pathogenesis (11 papers) and Immune Cell Function and Interaction (5 papers). Richard Woolf is often cited by papers focused on Dermatology and Skin Diseases (13 papers), Psoriasis: Treatment and Pathogenesis (11 papers) and Immune Cell Function and Interaction (5 papers). Richard Woolf collaborates with scholars based in United Kingdom, United States and Australia. Richard Woolf's co-authors include Catherine Smith, Teresa Tsakok, Stephan Weidinger, Carsten Flohr, A. David Burden, L.S. Exton, Adrian Hayday, Satveer K. Mahil, Yin Wu and Dhruva Biswas and has published in prestigious journals such as The Lancet, The Journal of Immunology and Science Translational Medicine.

In The Last Decade

Richard Woolf

26 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard Woolf United Kingdom	12	443	320	148	130	97	29	744
Witold Owczarek Poland	15	252 0.6×	350 1.1×	130 0.9×	154 1.2×	100 1.0×	92	800
Nikolai Loft Denmark	18	559 1.3×	516 1.6×	233 1.6×	75 0.6×	182 1.9×	51	1.0k
E. Archier France	10	398 0.9×	406 1.3×	87 0.6×	89 0.7×	46 0.5×	15	739
Shivani B. Kaushik United States	9	490 1.1×	407 1.3×	41 0.3×	48 0.4×	75 0.8×	10	786
Luca Mastorino Italy	15	275 0.6×	334 1.0×	75 0.5×	76 0.6×	124 1.3×	77	547
Wojciech Baran Poland	14	586 1.3×	388 1.2×	23 0.2×	92 0.7×	179 1.8×	66	967
Michael Bukhalo United States	10	518 1.2×	361 1.1×	39 0.3×	39 0.3×	110 1.1×	18	668
Annamaria Mazzotta Italy	16	756 1.7×	448 1.4×	28 0.2×	55 0.4×	129 1.3×	29	901
Wendell C. Valdecantos United States	17	503 1.1×	386 1.2×	50 0.3×	20 0.2×	84 0.9×	32	618
Fabrizio Martora Italy	17	365 0.8×	568 1.8×	38 0.3×	54 0.4×	62 0.6×	85	836

Countries citing papers authored by Richard Woolf

Since Specialization

Citations

This map shows the geographic impact of Richard Woolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Woolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Woolf more than expected).

Fields of papers citing papers by Richard Woolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Woolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Woolf. The network helps show where Richard Woolf may publish in the future.

Co-authorship network of co-authors of Richard Woolf

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Woolf. A scholar is included among the top collaborators of Richard Woolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Woolf. Richard Woolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meridor, Katya, Jane Freeston, Philip Laws, et al.. (2025). Development of a PsA-like presentation under anti-IL-13 therapy with tralokinumab for atopic dermatitis. Lara D. Veeken. 65(3).

Pink, Andrew, Richard Woolf, Paul Batty, et al.. (2025). Response to Lavin et al (2025)’s Paper: Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System. Journal of Investigative Dermatology. 145(9). 2325–2326.

Giménez‐Arnau, Ana M., Andreas Pinter, Wiebke Sondermann, et al.. (2025). Efficacy and safety of topical delgocitinib cream versus oral alitretinoin capsules in adults with severe chronic hand eczema (DELTA FORCE): a 24-week, randomised, head-to-head, phase 3 trial. The Lancet. 405(10490). 1676–1688. 6 indexed citations

Baudry, David, Bola Coker, Monica Arenas-Hernandez, et al.. (2025). Personalizing Biologic Therapy in Psoriasis: Development, Validation, and User Testing of a Precision-Dosing Dashboard. Journal of Investigative Dermatology. 145(9). 2251–2260. 2 indexed citations

Davies, Daniel, Shraddha Kamdar, Richard Woolf, et al.. (2024). PD-1 defines a distinct, functional, tissue-adapted state in Vδ1+ T cells with implications for cancer immunotherapy. Nature Cancer. 5(3). 420–432. 25 indexed citations

Hughes, Catherine, Joseph P. Nathan, Andrew Pink, et al.. (2023). Characterization of a Musculoskeletal Syndrome of Enthesitis and Arthritis in Patients With Atopic Dermatitis Treated With Dupilumab, an Interleukin‐4/13 Inhibitor. Arthritis & Rheumatology. 75(10). 1793–1797. 13 indexed citations

Bosma, Angela L., Louise A. A. Gerbens, Floris C. Loeff, et al.. (2023). The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort study. Journal of Dermatological Treatment. 34(1). 2193663–2193663. 2 indexed citations

Smith, Catherine, Zenas Z N Yiu, Tracy Bale, et al.. (2023). British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023: a pragmatic update. British Journal of Dermatology. 190(2). 270–272. 8 indexed citations

Raharja, Antony, Giulia Rinaldi, Teresa Tsakok, et al.. (2023). Real-World Implementation and Outcomes of Adalimumab Therapeutic Drug Monitoring in Psoriasis: A National Specialized Center Experience. Journal of Investigative Dermatology. 143(9). 1708–1716.e4. 3 indexed citations

10.

Barker, Juliet N., Francesca Capon, Andrew Pink, et al.. (2022). Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topic. British Journal of Dermatology. 188(4). 471–473. 9 indexed citations

11.

Smith, Catherine, Zenas Z N Yiu, Tracy Bale, et al.. (2020). British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update. British Journal of Dermatology. 183(4). 628–637. 130 indexed citations

12.

Mahil, Satveer K., Martinsixtus Ezejimofor, L.S. Exton, et al.. (2020). Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta‐analysis. British Journal of Dermatology. 183(4). 638–649. 60 indexed citations

13.

Smith, Catherine, Satveer K. Mahil, Zenas Z N Yiu, et al.. (2020). Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis–Correction. Journal of Investigative Dermatology. 141(1). 177–181. 6 indexed citations

14.

Wu, Yin, Richard Woolf, Cristina Naceur‐Lombardelli, et al.. (2019). An innate-like Vδ1 ⁺ γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer. Science Translational Medicine. 11(513). 139 indexed citations

15.

Woolf, Richard, Oliver Nussbaumer, & Adrian Hayday. (2017). 321 Human skin-resident innate-like T cells in health and disease. Journal of Investigative Dermatology. 137(10). S247–S247. 1 indexed citations

16.

Woolf, Richard, et al.. (2017). Exposure to biological therapies during conception and pregnancy: a systematic review. British Journal of Dermatology. 178(1). 95–102. 32 indexed citations

17.

Woolf, Richard, Sarah L. West, Monica Arenas-Hernandez, et al.. (2012). Methotrexate polyglutamates as a marker of patient compliance and clinical response in psoriasis: a single-centre prospective study. British Journal of Dermatology. 167(1). 165–173. 21 indexed citations

18.

Woolf, Richard & Alya Abdul‐Wahab. (2011). A pruritic rash in pregnancy. BMJ. 343(sep19 1). d5325–d5325. 1 indexed citations

19.

Woolf, Richard & Catherine Smith. (2010). How genetic variation affects patient response and outcome to therapy for psoriasis. Expert Review of Clinical Immunology. 6(6). 957–966. 16 indexed citations

20.

Anderson, Per, Anette Sundstedt, Zihni Açar Yazıcı, et al.. (2005). IL-2 Overcomes the Unresponsiveness but Fails to Reverse the Regulatory Function of Antigen-Induced T Regulatory Cells. The Journal of Immunology. 174(1). 310–319. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact